We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHKP icon
1076
Check Point Software Technologies
CHKP
$14.1B
$211K ﹤0.01%
3,138
+1,000
+47% +$66.1K
HMC icon
1077
Honda
HMC
$39.2B
$211K ﹤0.01%
5,995
RENX
1078
DELISTED
RELX N.V.
RENX
$211K ﹤0.01%
14,997
EWH icon
1079
iShares MSCI Hong Kong ETF
EWH
$1.24B
$210K ﹤0.01%
10,642
MDR
1080
DELISTED
McDermott International
MDR
$210K ﹤0.01%
9,000
-1,000
-10% -$25.2K
BLKB icon
1081
Blackbaud
BLKB
$1.67B
$209K ﹤0.01%
6,678
BRG
1082
DELISTED
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
$209K ﹤0.01%
11,252
-280
-2% -$5.2K
GL icon
1083
Globe Life
GL
$13.8B
$208K ﹤0.01%
4,001
-59,004
-94% -$3.03M
IYR icon
1084
iShares US Real Estate ETF
IYR
$4.78B
$208K ﹤0.01%
3,078
+80
+3% +$5.31K
ATNY
1085
DELISTED
API TECHNOLOGIES CORP. COMMON STOCK
ATNY
$208K ﹤0.01%
71,062
-2,100
-3% -$6.51K
AFFX
1086
DELISTED
Affymetrix Inc
AFFX
$207K ﹤0.01%
29,100
MAIN icon
1087
Main Street Capital
MAIN
$5.11B
$204K ﹤0.01%
6,250
-994
-14% -$33.8K
NFG icon
1088
National Fuel Gas
NFG
$7.74B
$204K ﹤0.01%
2,918
BNS icon
1089
Scotiabank
BNS
$108B
$203K ﹤0.01%
3,767
-217
-5% -$11.6K
EZU icon
1090
iShare MSCI Eurozone ETF
EZU
$9.46B
$202K ﹤0.01%
4,792
IEP icon
1091
Icahn Enterprises
IEP
$5.24B
$202K ﹤0.01%
1,968
-150
-7% -$16.5K
BIO icon
1092
Bio-Rad Laboratories Class A
BIO
$8.82B
$201K ﹤0.01%
1,575
BCS icon
1093
Barclays
BCS
$91.2B
$199K ﹤0.01%
13,701
XRAY icon
1094
Dentsply Sirona
XRAY
$2.68B
$197K ﹤0.01%
4,300
+207
+5% +$9.58K
BTU
1095
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$197K ﹤0.01%
810
-2,985
-79% -$757K
GDP
1096
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
$197K ﹤0.01%
12,500
-2,000
-14% -$31K
AZ
1097
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
$197K ﹤0.01%
11,735
BXP icon
1098
Boston Properties
BXP
$11B
$196K ﹤0.01%
1,720
+101
+6% +$11K
VDC icon
1099
Vanguard Consumer Staples ETF
VDC
$8.15B
$195K ﹤0.01%
1,775
+225
+15% +$24.2K
ATR icon
1100
AptarGroup
ATR
$8.73B
$194K ﹤0.01%
2,935
+265
+10% +$17.3K

Similar funds

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.